147 related articles for article (PubMed ID: 16507415)
1. The value of bone marrow aspirates culture for the detection of bone marrow micrometastasis in breast cancer.
Loo WT; Fong JH; Zhu L; Cheung MN; Chow LW
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S384-6. PubMed ID: 16507415
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases.
Talaat IM; Hachim MY; Hachim IY; Ibrahim RAE; Ahmed MAER; Tayel HY
Sci Rep; 2020 Aug; 10(1):13061. PubMed ID: 32747636
[TBL] [Abstract][Full Text] [Related]
3. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
7. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M; Iglesias-Díaz P; Díaz-Prado S; Ayude D; Medina V; Haz M; Reboredo M; Antolín S; Calvo L; Antón-Aparicio LM
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1185-95. PubMed ID: 19221791
[TBL] [Abstract][Full Text] [Related]
10. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
11. Bone-marrow micrometastases in patients with brain metastases from epithelial cell tumours.
Maguire D; O'Sullivan GC; McNamara B; Collins JK; Shanahan F
QJM; 2000 Sep; 93(9):611-5. PubMed ID: 10984556
[TBL] [Abstract][Full Text] [Related]
12. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.
Fox SB; Leek RD; Bliss J; Mansi JL; Gusterson B; Gatter KC; Harris AL
J Natl Cancer Inst; 1997 Jul; 89(14):1044-9. PubMed ID: 9230886
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow micrometastases in breast cancer patients.
Molino A; Pelosi G; Micciolo R; Turazza M; Nortilli R; Pavanel F; Cetto GL
Breast Cancer Res Treat; 1999 Nov; 58(2):123-30. PubMed ID: 10674876
[TBL] [Abstract][Full Text] [Related]
14. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
[TBL] [Abstract][Full Text] [Related]
15. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
16. Image analysis systems for the detection of disseminated breast cancer cells on bone-marrow cytospins.
Becker S; Becker-Pergola G; Fehm T; Emig R; Wallwiener D; Solomayer EF
J Clin Lab Anal; 2005; 19(3):115-9. PubMed ID: 15900568
[TBL] [Abstract][Full Text] [Related]
17. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow micrometastases in breast cancer patients.
Simmons R; Hoda S; Osborne M
Am J Surg; 2000 Oct; 180(4):309-12. PubMed ID: 11113442
[TBL] [Abstract][Full Text] [Related]
19. Micrometastatic bone marrow involvement: detection and prognostic significance.
Braun S; Pantel K
Med Oncol; 1999 Sep; 16(3):154-65. PubMed ID: 10523795
[TBL] [Abstract][Full Text] [Related]
20. The detection of isolated tumor cells in bone marrow comparing bright-field immunocytochemistry and multicolor immunofluorescence.
Krag DN; Kusminsky R; Manna E; Ambaye A; Weaver DL; Harlow SP; Covelli M; Stanley MA; McCahill L; Ittleman F; Leavitt B; Krag M
Ann Surg Oncol; 2005 Sep; 12(9):753-60. PubMed ID: 16079954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
